{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:58Z","timestamp":1740136378039,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10072-024-07753-9","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T13:03:24Z","timestamp":1726232604000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body image appearance in Parkinson\u2019s disease patients on device aided therapies"],"prefix":"10.1007","volume":"46","author":[{"given":"Francesca","family":"Proietti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Pontani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Magliozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Anzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Albergo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Ricciuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Lazzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-3666","authenticated-orcid":false,"given":"Massimo","family":"Marano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"s1","key":"7753_CR1","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/JPD-202104","volume":"10","author":"JM Dijk","year":"2020","unstructured":"Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA (2020) The Choice Between Advanced Therapies for Parkinson\u2019s Disease Patients: Why, What, and When? J Parkinsons Dis 10(s1):S65\u2013S73. https:\/\/doi.org\/10.3233\/JPD-202104","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"7753_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","volume":"19","author":"RMA de Bie","year":"2020","unstructured":"de Bie RMA, Clarke CE, Espay AJ, Fox SH, Lang AE (2020) Initiation of pharmacological therapy in Parkinson\u2019s disease: when, why, and how. Lancet Neurol 19(5):452\u2013461. https:\/\/doi.org\/10.1016\/S1474-4422(20)30036-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"7753_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mds.27882","volume":"35","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Mason S, Foltynie T, Winder-Rhodes S, Barker RA, Williams-Gray CH (2020) Motor complications in Parkinson\u2019s disease: 13-year follow-up of the CamPaIGN cohort. Mov Disord 35(1):185\u2013190. https:\/\/doi.org\/10.1002\/mds.27882","journal-title":"Mov Disord"},{"issue":"6","key":"7753_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","volume":"39","author":"S Prange","year":"2022","unstructured":"Prange S, Klinger H, Laurencin C, Danaila T, Thobois S (2022) Depression in Patients with Parkinson\u2019s Disease: Current Understanding of its Neurobiology and Implications for Treatment. Drugs Aging 39(6):417\u2013439. https:\/\/doi.org\/10.1007\/s40266-022-00942-1","journal-title":"Drugs Aging"},{"issue":"15","key":"7753_CR5","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? Mov Disord 25(15):2493\u20132500. https:\/\/doi.org\/10.1002\/mds.23394","journal-title":"Mov Disord"},{"key":"7753_CR6","doi-asserted-by":"publisher","unstructured":"Findley L, Eichorn T, Janca A, Kazenwadel J, Baker M , Currie-Gnjesda D, Koller W, Liebermann A, Mizuno Y, Rajput A, Roy S, Stocchi F, Tolosa E, Global Parkinson's Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 17(1):60\u201367. https:\/\/doi.org\/10.1002\/mds.10010","DOI":"10.1002\/mds.10010"},{"issue":"3A","key":"7753_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/s0004-282x2009000400002","volume":"67","author":"AH Gamarra","year":"2009","unstructured":"Gamarra AH, Molski CS, Hilbig A, Valentini CK, Striebel VL, Rieder CR (2009) Evaluation of body image and self-concept and their correlation with depressive symptoms in Parkinson\u2019s disease. Arq Neuropsiquiatr 67(3A):585\u2013590. https:\/\/doi.org\/10.1590\/s0004-282x2009000400002","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"7753_CR8","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/brainsci13101410","volume":"13","author":"D Sattin","year":"2023","unstructured":"Sattin D, Parma C, Lunetta C, Zulueta A, Lanzone J, Giani L, Vassallo M, Picozzi M, Parati EA (2023) An Overview of the Body Schema and Body Image: Theoretical Models, Methodological Settings and Pitfalls for Rehabilitation of Persons with Neurological Disorders. Brain Sci 13(10):1410. https:\/\/doi.org\/10.3390\/brainsci13101410","journal-title":"Brain Sci"},{"issue":"1","key":"7753_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12883-022-02554-z","volume":"22","author":"A Stefani","year":"2022","unstructured":"Stefani A, Tessitore A, Tambasco N, Cossu G, Ceravolo MG, Defazio G, Morgante F, Ramat S, Melzi G, Gualberti G, Merolla R, Onuk K, Lopiano L (2022) Criteria for identification of advanced Parkinson\u2019s disease: the results of the Italian subgroup of OBSERVE-PD observational study. BMC Neurol 22(1):41. https:\/\/doi.org\/10.1186\/s12883-022-02554-z","journal-title":"BMC Neurol"},{"key":"7753_CR10","volume-title":"APA Dictionary of Psychology, American Psychological Association: Washington","author":"GR VandenBos","year":"2007","unstructured":"VandenBos GR (2007) APA Dictionary of Psychology, American Psychological Association: Washington. DC, USA"},{"issue":"1","key":"7753_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF02229242","volume":"20","author":"TF Cash","year":"1996","unstructured":"Cash TF, Labarge AS (1996) Development of the Appearance Schemas Inventory: A new cognitive body-image assessment. Cogn Ther Res 20(1):37\u201350. https:\/\/doi.org\/10.1007\/BF02229242","journal-title":"Cogn Ther Res"},{"issue":"3","key":"7753_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/eat.10264","volume":"35","author":"TF Cash","year":"2004","unstructured":"Cash TF, Melnyk SE, Hrabosky JI (2004) The assessment of body image investment: an extensive revision of the appearance schemas inventory. Int J Eat Disord 35(3):305\u2013316. https:\/\/doi.org\/10.1002\/eat.10264","journal-title":"Int J Eat Disord"},{"key":"7753_CR13","unstructured":"Toosi M (2016) Self-evaluative salience and motivational salience as predictors of depressive affect and appearance based rejection sensitivity. Walden University. https:\/\/scholarworks.waldenu.edu\/cgi\/viewcontent.cgi?article=3489&context=dissertations"},{"issue":"4","key":"7753_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bodyim.2006.09.001","volume":"3","author":"TA Jakatdar","year":"2006","unstructured":"Jakatdar TA, Cash TF, Engle EK (2006) Body-image thought processes: The development and initial validation of the Assessment of Body-Image Cognitive Distortions. Body Image 3(4):325\u2013333. https:\/\/doi.org\/10.1016\/j.bodyim.2006.09.001","journal-title":"Body Image"},{"issue":"5","key":"7753_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1532-5415.1968.tb02103.x","volume":"16","author":"BS Linn","year":"1968","unstructured":"Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16(5):622\u2013626. https:\/\/doi.org\/10.1111\/j.1532-5415.1968.tb02103.x","journal-title":"J Am Geriatr Soc"},{"key":"7753_CR16","unstructured":"Derogatis LR, Savitz KL (1999) The SCL-90-R, Brief Symptom Inventory, and Matching Clinical Rating Scales. In:  Maruish ME (ed) The use of psychological testing for treatment planning and outcomes assessment, 2nd edn. Lawrence Erlbaum Associates Publishers, New Jersey, pp 679\u2013724"},{"issue":"7","key":"7753_CR17","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1007\/s00415-024-12400-6","volume":"271","author":"M Marano","year":"2024","unstructured":"Marano M, Pilotto A, Padovani A, Gupta D, Vivacqua G, Magliozzi A, Di Lazzaro V, Carta M, Meloni M (2024) The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson\u2019s disease. J Neurol 271(7):3711\u20133720. https:\/\/doi.org\/10.1007\/s00415-024-12400-6","journal-title":"J Neurol"},{"issue":"Suppl 7","key":"7753_CR18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00586-015-4265-7","volume":"24","author":"L Bissolotti","year":"2015","unstructured":"Bissolotti L, Isacco-Grassi F, Orizio C, Gobbo M, Berjano P, Villafa\u00f1e JH, Negrini S (2015) Spinopelvic balance and body image perception in Parkinson\u2019s disease: analysis of correlation. Eur Spine J 24(Suppl 7):898\u2013905. https:\/\/doi.org\/10.1007\/s00586-015-4265-7","journal-title":"Eur Spine J"},{"issue":"3","key":"7753_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12529-015-9524-9","volume":"23","author":"NR Gawlik","year":"2016","unstructured":"Gawlik NR, Elias AJ, Bond MJ (2016) Appearance Investment, Quality of Life, and Metabolic Control Among Women with Type 1 Diabetes. Int J Behav Med 23(3):348\u2013354. https:\/\/doi.org\/10.1007\/s12529-015-9524-9","journal-title":"Int J Behav Med"},{"issue":"1","key":"7753_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.36131\/cnfioritieditore20240105","volume":"21","author":"S Casale","year":"2024","unstructured":"Casale S, Pettini C, Fioravanti G, Padovani M, Ghinassi S (2024) The Link Between Problematic Instagram Use and Body-Image Investment Dimensions: The Meanting Role of Social Comparison on Instagram and the Need to Conceal Body Flaws. Clin Neuropsychiatry 21(1):79\u201387. https:\/\/doi.org\/10.36131\/cnfioritieditore20240105","journal-title":"Clin Neuropsychiatry"},{"key":"7753_CR21","doi-asserted-by":"publisher","first-page":"137850","DOI":"10.1016\/j.neulet.2024.137850","volume":"836","author":"M Marano","year":"2024","unstructured":"Marano M, Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Peppe A (2024) The influence of sex on non-motor wearing-off in Parkinson\u2019s disease: A WORK-PD post-hoc study. Neurosci Lett 836:137850. https:\/\/doi.org\/10.1016\/j.neulet.2024.137850","journal-title":"Neurosci Lett"},{"issue":"3","key":"7753_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3233\/JPD-201978","volume":"10","author":"HR Moes","year":"2020","unstructured":"Moes HR, Groenendal-Laurensse JWMJ, Drent M, Tissingh G, van Laar T (2020) Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study. J Parkinsons Dis 10(3):935\u2013944. https:\/\/doi.org\/10.3233\/JPD-201978","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"7753_CR23","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1007\/s00415-022-11269-7","volume":"269","author":"F Garr\u00ec","year":"2022","unstructured":"Garr\u00ec F, Russo FP, Carrer T, Weis L, Pistonesi F, Mainardi M, Sandre M, Savarino E, Farinati F, Del Sorbo F, Soliveri P, Calandrella D, Biundo R, Carecchio M, Zecchinelli AL, Pezzoli G, Antonini A (2022) Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson\u2019s disease on levodopa\/carbidopa intestinal gel infusion. J Neurol 269(10):5606\u20135614. https:\/\/doi.org\/10.1007\/s00415-022-11269-7","journal-title":"J Neurol"},{"key":"7753_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2020.03.024","volume":"73","author":"R Cerroni","year":"2020","unstructured":"Cerroni R, Scalise S, Imbriani P, Liguori C, Pierantozzi M, Pisani A, Mercuri NB, Stefani A (2020) Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. Parkinsonism Relat Disord 73:57\u201359. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.03.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"7753_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3233\/JPD-181462","volume":"9","author":"J Angulo","year":"2019","unstructured":"Angulo J, Fleury V, P\u00e9ron JA, Penzenstadler L, Zullino D, Krack P (2019) Shame in Parkinson\u2019S Disease: A Review. J Parkinsons Dis 9(3):489\u2013499. https:\/\/doi.org\/10.3233\/JPD-181462","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"7753_CR26","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3390\/ijerph19052745","volume":"19","author":"E Gualdi-Russo","year":"2022","unstructured":"Gualdi-Russo E, Rinaldo N, Masotti S, Bramanti B, Zaccagni L (2022) Sex Differences in Body Image Perception and Ideals: Analysis of Possible Determinants. Int J Environ Res Public Health 19(5):2745. https:\/\/doi.org\/10.3390\/ijerph19052745","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"7753_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1570159X17666191016094857","volume":"18","author":"F Assogna","year":"2020","unstructured":"Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano GR, Alborghetti M, Caltagirone C, Spalletta G, Pontieri FE (2020) Drug Choices and Advancements for Managing Depression in Parkinson\u2019s Disease. Curr Neuropharmacol 18(4):277\u2013287. https:\/\/doi.org\/10.2174\/1570159X17666191016094857","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"7753_CR28","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J, \u015ami\u0142owska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E (2022) European Academy of Neurology\/Movement Disorder Society - European Section guideline on the treatment of Parkinson\u2019s disease: I Invasive therapies. Eur J Neurol 29(9):2580\u20132595. https:\/\/doi.org\/10.1111\/ene.15386","journal-title":"Eur J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07753-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T11:08:21Z","timestamp":1735902501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07753-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7753"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07753-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present work has been approved by the local ethic committee, all patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}},{"value":"Authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}